US 9944603
Compounds and methods for the treatment of cystic fibrosis
granted A61KA61K31/4245A61K31/437
Quick answer
US patent 9944603 (Compounds and methods for the treatment of cystic fibrosis) held by Flatley Discovery Lab, LLC expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Flatley Discovery Lab, LLC
- Grant date
- Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/4245, A61K31/437, A61K31/443, A61K31/4468